• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    SciSparc Ltd. - Ordinary Shares (NQ:SPRC)

    0.4801 -0.0201 (-4.02%)
    Streaming Delayed Price Updated: 3:59 PM EST, Mar 3, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about SciSparc Ltd. - Ordinary Shares

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    16 17 Next >
    News headline image
    SciSparc Announces 1-for-9 Reverse Share Split
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc Successfully Completes Acquisition of IP Portfolio, Advances Toward Immediate Commercialization
    From SciSparc Ltd
    Via GlobeNewswire
    Which stocks are moving after the closing bell on Wednesday? ↗
    Via Chartmill
    These stocks are gapping in today's session ↗
    Via Chartmill
    These stocks that are showing activity before the opening bell on Tuesday. ↗
    Via Chartmill
    News headline image
    SciSparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    Get insights into the top gainers and losers of Friday's after-hours session. ↗
    Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
    Via Chartmill
    News headline image
    These stocks are moving in today's after hours session ↗
    Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
    Via Chartmill
    News headline image
    SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    Traders are paying attention to the gapping stocks in Wednesday's session. ↗
    Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session. 
    Via Chartmill
    News headline image
    Wednesday's pre-market session: top gainers and losers ↗
    The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
    Via Chartmill
    News headline image
    SciSparc Stock Soars Pre-Market After Snapping Up Patents For Next-Gen Endoscopy Tech ↗
    In return, SciSparc shall issue to Xylo an amount of ordinary shares of the company. 
    Via Stocktwits
    Topics Intellectual Property
    News headline image
    SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    These stocks that are showing activity before the opening bell on Tuesday. ↗
    Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
    Via Chartmill
    News headline image
    SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    News headline image
    SciSparc Announces Closing of the Acquisition of a Publicly Traded Company on the TSXV to which it transferred its Advanced Clinical Stage Pharmaceutical Portfolio
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc Announces Closing of the Sale to N2OFF of Majority-Owned Subsidiary MitoCareX, Advancing Drug Discovery for Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc Targets Quantum-Powered 3D Protein Modeling Technology to Revolutionize AI Drug Discovery
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    News headline image
    SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures ↗
    SciSparc traded higher after the company announced it had signed a definitive agreement to acquire a controlling stake in Miza III Ventures. 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    SciSparc Enters into Definitive Agreement for the Acquisition of a Publicly Traded Company on the TSXV to which it will transfer its Advanced Clinical Stage Pharmaceutical Portfolio
    From SciSparc Ltd
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    16 17 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.